Clinical Trials Logo
  1. Home
  2. Other
  3. NCT00540904

Prevention of Contrast Induced Nephropathy in Oncology Patients With Sodium Bicarbonate

Radiographic Contrast Agent Nephropathy Clinical Trial

Official title:
Prevention of Contrast Induced Nephropathy in Oncology Patients With Sodium Bicarbonate

Clinical Trial Summary

Contrast induced nephropathy is a rising cause of acute renal failure in all patients. A study published in JAMA 2004, show a superiority of a hydratation with sodium bicarbonate in comparison with the same volume hydratation with sodium bicarbonate. The investigators will try following the original protocol making 2 randomized groups of patients, with cancer diagnosis, >18 years old, with a GFR <60 and >30 ml/min/1,73m2 by MDRD formula and/or diabetic patients. In the group 1 the patients will receive a solution with 154 mEq/L of a sodium bicarbonate, 3 cc/Kg/h at 1 hour before the injection of contrast and 1 cc/Kg/h during and 6 hours before the injection. The primary end point will be the rise of 25% or more in creatinine or dialysis needed.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00540904
Study type Interventional
Source Barretos Cancer Hospital
Contact
Status Completed
Phase Phase 2
Start date September 2007
Completion date September 2009
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT00584350 - Prevention of Contrast Nephropathy During Diagnostic Coronary Angiogram or PCI With Hydratation Based on LEVDP Phase 4
Recruiting NCT01820195 - N-Acetyl Cystein and Contrast Nephropathy Phase 3
Completed NCT02137863 - Efficacy of Dexmedetomidine in Preventing Contrast Induced Nephropathy Phase 4
Completed NCT01866800 - The Effect of the Forced Diuresis With Matched Hydration in Reducing Acute Kidney Injury During TAVI Phase 4
Active, not recruiting NCT01778140 - Comparing Effects of Patient-specific Versus Non-patient-specific Computerized Reminder System N/A
Completed NCT02483143 - NAC, NaHCO3 and NS Prophylaxis for CTPA in the ED on Suspicion of PE: A Randomized Controlled Trial Phase 4
Completed NCT01525888 - Renin-angiotensin-aldosterone System (RAAS) Blockade and Contrast Induced Nephropathy N/A
Recruiting NCT02643706 - Relationship Between ALDH2 and CIN N/A
Terminated NCT01168024 - Contrast Media Reduction and Removal in Patients With CKD (PRESERV) Phase 3
Completed NCT02643602 - Does Bicarbonate in Addition to Theophylline Reduce CIN? N/A
Recruiting NCT02029820 - RenalGuard System for Prevention of Contrast Induced Nephropathy Phase 3
Terminated NCT01654328 - Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy N/A